Kirkland & Ellis advised Pathfinder Acquisition Corporation on the deal, Pillsbury Winthrop Shaw Pittman advised Movella, Latham & Watkins advised Francisco Partners. Pathfinder Acquisition Corporation (NASDAQ:...
Pathfinder Acquisition Corporation’s Business Combination with Movella
KKR’s $410 Million Investment in NetSPI
Latham & Watkins represented KKR, while Goodwin Procter advised NetSPI in the transaction. NetSPI, a leader in enterprise penetration testing and attack surface management, announced that...
Duolingo’s Acquisition of Gunner
Latham & Watkins represented Duolingo in the transaction. Duolingo has announced that it has acquired Gunner, a Detroit-based animation studio startup, to grow its language learning...
CommerceHub’s Acquisition of ChannelAdvisor
Cooley advised ChannelAdvisor, while Willkie Farr & Gallagher and Paul, Weiss, Rifkind, Wharton & Garrison advised CommerceHub. Kirkland & Ellis represented GTCR and Sycamore Partners and Simpson...
DigitalOcean’s $350 Million Acquisition of Cloudways
Cooley advised DigitalOcean Holdings on the deal, while Latham & Watkins represented Cloudways. DigitalOcean Holdings, the cloud for developers, startups, and small and midsize business (SMBs),...
Level Access’s Merger With eSSENTIAL Accessibility
Fasken Martineau DuMoulin LLP acted for eSSENTIAL Accessibility. Latham & Watkins represented KKR in the transaction. Level Access, the trusted provider of enterprise digital accessibility solutions, and eSSENTIAL...
UNITY Biotechnology’s $45 Million Shares Offering
Latham & Watkins represented UNITY Biotechnology in the transaction. UNITY Biotechnology, Inc. (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, has...
Terns Pharmaceuticals’ $65 Million Common Stock Offering
Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...
Colonnade Acquisition Corp. II’s Business Combination with Plastiq
White & Case represented Colonnade, while Latham & Watkins represented Plastiq in the transaction. Colonnade Acquisition Corp. II, a special purpose acquisition company (NYSE: CLAA), announced...
CONMED’s $85 Million Acquisition of Biorez
Sullivan & Cromwell LLP and DLA Piper LLP acted as legal counsel for CONMED, while Shipman & Goodwin LLP, Burns & Levinson LLP, and Latham &...
Lindsay Goldberg’s Investment into MMS Holdings
Latham & Watkins represented Lindsay Goldberg in the transaction. MMS Holdings Inc. (MMS), a leading data-focused contract research organization (CRO), has announced that Lindsay Goldberg, a...
Rhythm Pharmaceuticals’ $100 Million Revenue Interest Financing Agreement With HealthCare Royalty Partners
Latham & Watkins represented Rhythm Pharmaceuticals, Inc. in the transaction, while Morgan, Lewis & Bockius acted as legal advisor to HealthCare Royalty. Rhythm Pharmaceuticals, Inc. (Nasdaq:...